MétaCan
Menu
Retour à la cohorte
Enregistrement W4410011040 · doi:10.1097/01.cot.0000000000000050

Obesity Affects Survival After Cancer Diagnosis in Children

2025· article· en· W4410011040 sur OpenAlexaboutno aff
Mark L. Fuerst

Notice bibliographique

RevueOncology Times · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueChildhood Cancer Survivors' Quality of Life
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésObesityCancerMedicineCancer survivalEnvironmental healthGerontologyInternal medicine

Résumé

récupéré en direct d'OpenAlex

A recent population-based study indicates that obese children at the time of cancer diagnosis may face an elevated risk of dying. The retrospective study indicates that obesity at diagnosis is an independent predictor of inferior survival, prominently in children with acute lymphoblastic leukemia (ALL) and central nervous system (CNS) tumors (Cancer 2025; https://doi.org/10.1002/cncr.35673). The study was based on information from Cancer in Young People, a Canadian database, including all children with newly diagnosed cancer, ages 2-18 years, across Canada from 2001 to 2020. Obesity was defined as age- and sex-adjusted body mass index at or above the 95th percentile. Among 11,291 children with cancer, 10.5 percent were obese at the time of diagnosis. Investigators assessed 5-year event-free survival (EFS) and overall survival (OS). Compared with patients without obesity at the time of initial cancer diagnosis, those with obesity had lower rates of 5-year EFS (77.5% vs. 79.6%) and OS (83% vs. 85.9%). After adjusting for factors including age, sex, ethnicity, neighborhood income quintile, treatment era, and cancer categories, obesity at diagnosis was linked with a 16 percent increase in the risk of relapse and a 29 percent increase in the risk of death. “Our study highlights the negative impact of obesity among all types of childhood cancers. It provides the rationale to evaluate different strategies to mitigate the adverse risk of obesity on cancer outcomes in future trials,” said co-senior author Thai Hoa Tran, MD, FRCPC, Pediatric Hematologist-Oncologist in the Leukemia Program at the Centre Hospitalier Universitaire Sainte-Justine in Montreal. “It also reinforces the urgent need to reduce the epidemic of childhood obesity, as it can result in significant health consequences.” Obesity increases the risk of various cancers in adults and has been associated with unfavorable outcomes in several cancer types, including breast, colorectal, uterine, prostate, and pancreatic cancers. A growing body of literature suggests that being overweight or obese at diagnosis confers adverse outcomes in children with cancer, particularly those with ALL. Researchers from all across Canada sought to assess the prevalence of obesity and its prognostic significance in children and adolescents diagnosed with cancer. The negative impact of obesity on prognosis was especially pronounced in patients with ALL and CNS tumors. In 3,458 children with ALL, obesity remained associated with inferior EFS (adjusted hazard ratio: 1.55) and OS (adjusted hazard ratio: 1.75) in multivariable analysis. In 2,458 patients with CNS tumors, obesity was also associated with inferior EFS (adjusted hazard ratio: 1.38) and OS (adjusted hazard ratio: 1.47). No statistically significant differences were observed in other cancer types, notably acute myeloid leukemia, lymphomas, and non-CNS solid tumors. “Our findings consolidate the adverse impact of obesity on cancer outcomes in a large population-based cohort of childhood cancers, thereby echoing the growing literature in both pediatric and adult oncology,” the researchers stated. “Obesity at diagnosis remains independently associated with an approximately 55 percent increase in the risk of an event and a 75 percent increase in the risk of death after adjusting for recognized prognostic factors, further strengthening the association between obesity and poor outcomes in childhood ALL.” The study also highlights the risks of obesity in children and adolescents with CNS tumors, a prognostic factor that has not been reported previously. The effect of obesity in children with CNS tumors was more prominent in gliomas and glioneural tumors. The researchers noted that the potential undertreatment and inappropriate dosing of chemotherapeutic agents remain important concerns for obese patients. This may be due to how body composition affects drug absorption, metabolism, protein binding, blood-to-tissue delivery, and drug clearance. “Individualized therapeutic drug monitoring in obese patients during active treatment is urgently needed to inform rationalized chemotherapy dosage and optimize cancer outcomes. In contrast, if obesity causes excessive treatment-related mortality without excess relapse, therapy de-escalation and/or enhanced supportive care would appear to be appropriate measures,” the researchers stated. Further studies are needed to better characterize the pathophysiologic mechanisms linking obesity and survival in pediatric oncology, the researchers concluded. Mark L. Fuerst is a contributing writer.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesCharge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,035
Score d'incertitude au seuil0,999

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0010,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0020,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,013
Tête enseignante GPT0,338
Écart entre enseignants0,325 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueOncology TimesMême sujetChildhood Cancer Survivors' Quality of LifeTravaux en français237 207